Document is current
Any future updates will be listed below
-
Authors
Beauregard, Jean-Mathieu https://orcid.org/0000-0003-2123-145X
-
Funding
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé
- License Information
-
More Information
Article History
Received: 10 October 2022
Accepted: 14 November 2022
First Online: 9 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: JMB has received consultant honoraria from Novartis and is an investigator for Point Biopharma.
